文献速递心血管USMRPET

心脏淀粉样变性诊断影像学的趋势:新知识与新概念

Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts.
PubMed 文献 · Radiographics · 2020-05-22

心脏淀粉样变性长期被视为罕见病,但心脏影像学进展使心力衰竭患者中隐藏的病例识别增加,提示实际发病率被低估。该综述更新其临床特征,并讨论超声心动图、心脏MRI和核医学等无创诊断影像的当前趋势。早期诊断和有效治疗干预是改善预后的关键。

要点

  • 心脏影像学进展使心衰患者中隐藏的心脏淀粉样变性识别增加,提示实际发病率被低估。
  • 超声心动图、心脏MRI和核医学等无创影像有助于心脏淀粉样变性的精准早期诊断并启动适当管理。
  • 早期诊断和有效治疗干预是改善心脏淀粉样变性预后的关键 contributors。

核心结论

  • 近期心脏影像学进展使心衰患者中隐藏的心脏淀粉样变性识别增加,提示实际发病率被低估。
  • 早期诊断和涉及有效治疗的干预是改善预后的关键 contributors。
  • 近期无创诊断影像技术促进心脏淀粉样变性的精准早期诊断并启动适当管理。

研究设计与样本

  • 本文为更新综述,讨论心脏淀粉样变性的临床特征及无创诊断影像的当前趋势。

临床应用与阅片要点

  • 作者提出更新综述,涵盖心脏淀粉样变性的临床特征并讨论无创诊断影像的当前趋势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Cardiac amyloidosis (CA) has long been recognized as a rare disease. However, recent advances in cardiac imaging have led to increased identification of hidden CA in patients diagnosed with heart failure. This shift suggests that the actual incidence of CA is underestimated. The prognosis of CA is generally poor, especially in patients with advanced heart failure. However, recent developments in therapeutic interventions have improved the survival of patients with CA. An early diagnosis and interventions involving effective therapies are essential contributors to improved prognoses. Recent noninvasive diagnostic imaging modalities such as echocardiography, cardiac MRI, and nuclear imaging have facilitated the precise and early diagnosis of CA and enabled the initiation of appropriate management. The authors present an updated review of the clinical features of CA, including a discussion of current trends in noninvasive diagnostic imaging. ©RSNA, 2020.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Oda S, Kidoh M, Nagayama Y, et al. Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts. Radiographics. 2020. PMID: 32442047. doi:10.1148/rg.2020190069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。